STOCK TITAN

FS KKR Capital (NYSE: FSK) amends $150M tender; $900M 7.50% notes added

(Neutral)
(Neutral)
Form Type
SC TO-T/A

Rhea-AI Filing Summary

FS KKR Capital Corp. amends its tender offer to purchase up to $150,000,000 aggregate amount of common stock at $11.00 per share, as set forth in the Offer to Purchase. The Amendment clarifies past contacts and adds disclosure of a related underwriting agreement.

The Amendment restates the disclosure concerning the Company’s $900 million offering of 7.500% notes due 2031, including a 1.00% underwriting discount, customary make-whole redemption terms, a change of control repurchase event, and an expected closing on June 8, 2026. The Amendment does not itself offer or solicit the sale of securities.

Positive

  • None.

Negative

  • None.

Insights

Notes offering details added; underwriters and basic economics disclosed.

The Amendment adds an underwriting agreement for $900 million of 7.500% notes due 2031, a 1.00% underwriting discount, and customary redemption and change-of-control repurchase provisions. It states an expected closing date of June 8, 2026.

Primary dependencies include customary closing conditions and the Company’s use of net proceeds for general corporate purposes, including potential repayment of indebtedness. Subsequent regulatory filings (the referenced 8-K and prospectus/exhibits) will provide full terms and final proceeds treatment.

Tender offer remains targeted at $150M at $11.00; amendment adds context on related financings.

The Schedule TO amendment confirms the Purchaser’s offer to acquire up to $150,000,000 of shares at $11.00 per share and supplements Item 5 with the Underwriting Agreement for the Company’s note issuance. The Amendment notes potential use of proceeds to repay credit facilities and certain notes.

Cash-flow treatment and exact allocation of proceeds are described in summary form; detailed effects on leverage and liquidity depend on the final closing and any elected uses of proceeds disclosed in the Company’s offering documents.

Tender offer size $150,000,000 aggregate amount of shares to be purchased at $11.00 per share
Tender offer price $11.00 per share price offered in the Offer to Purchase
Notes offering principal $900,000,000 aggregate principal amount of 7.500% Notes due 2031
Notes coupon 7.500% annual interest rate on the Notes due 2031
Underwriting discount 1.00% underwriting discount on principal amount of Notes purchased by each underwriter
Notes expected closing June 8, 2026 expected closing date of the Notes offering
Notes maturity August 1, 2031 maturity date of the 7.500% Notes
Tender Offer financial
"offer to purchase up to $150,000,000 in aggregate amount of shares"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
Underwriting Agreement financial
"entered into an underwriting agreement by and among the Company and the Adviser"
An underwriting agreement is a contract where a company selling new stocks or bonds hires financial firms to buy those securities and resell them to investors. It matters because the agreement sets the offering price, number of securities, fees and which party bears the risk if sales fall short—think of it as a promise that the sale will happen and a roadmap investors can use to understand how the new securities reach the market.
make-whole premium financial
"redeemed prior to May 1, 2031, a “make-whole” premium"
A make-whole premium is an extra payment a borrower must give bondholders when repaying debt early to compensate them for lost future interest; think of it as a lump-sum “catch-up” to leave lenders financially where they would have been if the loan had run its full term. It matters to investors because it affects how much they receive on early redemption and influences a company’s decision to refinance or repay debt, altering bond value and expected returns.
change of control repurchase event regulatory
"on the occurrence of a “change of control repurchase event” the Company will be required"
A change of control repurchase event happens when a company is sold or otherwise taken over and that sale triggers contractual rights for holders of stock, options, or debt to force the company to buy their securities back for cash. Think of it like a lease that lets the tenant cash out when the building is sold: it gives certain investors a predictable exit price and timeline. This matters because it can change who owns the company, alter cash on hand, affect future returns and dilution, and influence how attractive a takeover or investment looks.
asset coverage requirements regulatory
"covenants requiring the Company to comply with the asset coverage requirements of Section 18(a)(1)(A)"
A rule or covenant that specifies the minimum value of a company’s assets that must be held to back its debts, obligations or issued securities. It’s like a lender or regulator asking someone to keep enough cash in the bank to cover outstanding loans; for investors, stronger asset coverage means lower risk of loss if the company faces trouble, while weak coverage raises default or dilution concerns.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the FSK amendment change about the tender offer?

The amendment confirms the tender offer remains for $150,000,000 of common stock at $11.00 per share. It supplements Item 5 with disclosure about a related underwriting agreement for the company’s notes due 2031.

How large is the company’s notes offering disclosed in the amendment?

The amendment discloses an underwriting agreement for $900 million aggregate principal amount of 7.500% notes due 2031. The offering is described as expected to close on June 8, 2026.

Will FSK use notes proceeds to repay debt?

The amendment states the Company intends to use net proceeds for general corporate purposes, including potentially repaying outstanding indebtedness under credit facilities and certain notes. Exact allocations are not detailed in the excerpt.

What are key economic terms of the notes disclosed?

The notes carry a 7.500% coupon, mature on August 1, 2031, include a customary make-whole if redeemed before May 1, 2031, and underwriters receive a 1.00% discount on principal purchased.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549



SCHEDULE TO
(Amendment No. 2)

Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1)
of the Securities Exchange Act of 1934



FS KKR Capital Corp.
(Name of Subject Company (Issuer))

KKR Alternative Assets L.P.
KKR Alternative Assets Limited
(Name of Filing Person (Offeror))

Common stock, par value $0.001 per share
(Title of Class of Securities)

302635206
(CUSIP Number of Class of Securities)

Noah Greenhill, Esq.
KKR Alternative Assets L.P.
30 Hudson Yards
New York, NY 10001
(212) 750-8300

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Persons)



Copies to:

Kenneth Wallach, Esq.
Lesley Peng, Esq.
Patrick Baron, Esq.
Simpson Thacher & Bartlett LLP
425 Lexington Avenue
New York, NY 10017
(212) 455-2000

 (Name, address, and telephone numbers of person authorized to receive notices and communications on behalf of filing persons)



Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

third-party tender offer subject to Rule 14d-1.

issuer tender offer subject to Rule 13e-4.

going private transaction subject to Rule 13e-3

amendment to Schedule 13D under Rule 13d-2

Check the following box if the filing is a final amendment reporting the results of the tender offer: 

If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

Rule 13e-4(i) (Cross-Border Issuer Tender Offer)

Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)




This Amendment No. 2 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO originally filed by KKR Alternative Assets L.P., a Delaware limited partnership (the “Purchaser”), on May 12, 2026, as amended by Amendment No. 1 filed on May 22, 2026 (as amended, the “Schedule TO”) in connection with the Purchaser’s offer to purchase up to $150,000,000 in aggregate amount of shares of common stock, par value $0.001 per share (the “Shares”), of FS KKR Capital Corp., a Maryland corporation, at a price equal to $11.00 per share, less any applicable withholding taxes and without interest, upon the terms and subject to the conditions set forth in the Offer to Purchase dated May 12, 2026, as amended by Amendment No. 1 to the Schedule TO (the “Offer to Purchase”), which was previously filed with the Schedule TO as Exhibit (a)(1)(A), and in the related Letter of Transmittal, which was previously filed with the Schedule TO as Exhibit (a)(1)(B), which, together with Amendment No. 1 to the Schedule TO and this Amendment collectively constitute the “Offer.”

KKR Alternative Assets Limited, the general partner of the Purchaser, is being named as a bidder in in this Amendment because it is deemed to control the Purchaser, but otherwise is not participating in the Offer.

Except as otherwise set forth in this Amendment, the information set forth in the Schedule TO remains unchanged and is incorporated herein by reference to the extent relevant to the Items in this Amendment. This Amendment should be read together with the Schedule TO. Capitalized terms used and not otherwise defined in this Amendment shall have the meanings assigned to such terms in the Schedule TO and the Offer to Purchase.

Item 5.          Past Contacts, Transactions, Negotiations and Agreements.

The disclosure in the Offer to Purchase and Item 5 of the Schedule TO, to the extent such Item incorporates by reference the information contained in the Offer to Purchase, is hereby amended as follows:

Section 10—“Background of the Offer; Past Contacts, Transactions, Negotiations and Agreements—Past Contacts, Transactions, Negotiations and Agreements” is amended and supplemented by deleting the seventeenth paragraph and restating it as follows:

7.500% Unsecured Notes Underwriting Agreement. On June 1, 2026, the Company entered into an underwriting agreement (the “Underwriting Agreement”) by and among the Company and the Adviser, on one hand, and BofA Securities, Inc., BMO Capital Markets Corp., J.P. Morgan Securities LLC, KKR Capital Markets LLC, RBC Capital Markets, LLC and SMBC Nikko Securities America, Inc., on the other hand as representatives of the underwriters named in Schedule A thereto, in connection with the issuance and sale of $900 million aggregate principal amount of the Company’s 7.500% Notes due 2031 (the “Notes”). Each underwriter will receive payment of a 1.00% underwriting discount on the principal amount of Notes purchased by such underwriter pursuant to the terms of the Underwriting Agreement.

The Notes will mature on August 1, 2031 and may be redeemed in whole or in part at the Company’s option at any time at par plus, if redeemed prior to May 1, 2031, a “make-whole” premium. In addition, on the occurrence of a “change of control repurchase event,” the Company will be required to make an offer to purchase the outstanding Notes at a price equal to 100% of the principal amount of such Notes plus accrued and unpaid interest to the repurchase date. The indenture that will govern the Notes will contain certain covenants, including covenants requiring the Company to comply with the asset coverage requirements of Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act of 1940, as amended, whether or not it is subject to those requirements, and to provide financial information to the holders of the Notes and the trustee if the Company is no longer subject to the reporting requirements under the Securities Exchange Act of 1934, as amended. The offering is expected to close on June 8, 2026, subject to customary closing conditions. The Company intends to use the net proceeds from the Notes offering for general corporate purposes, including potentially repaying outstanding indebtedness under credit facilities and certain notes.

The foregoing summaries do not purport to be complete. The Purchase Agreement, the Equity Distribution Agreements, the Advisory Agreement, the Administration Agreement and the Underwriting Agreement are qualified in their entirety to the full text of such agreements, which are filed as exhibits to the Schedule TO. Please refer to the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2025 and its most recent definitive proxy statement relating to an annual meeting of stockholders and other SEC filings for more information regarding related-party transactions and related matters.”

This Amendment does not constitute an offer to sell any securities of the Company and it does not constitute a solicitation of an offer to buy any securities of the Company in any state or jurisdiction where such offer and sale is not permitted.



Item 12.          Exhibits.

(a)(1)(A)
Offer to Purchase (incorporated by reference to Exhibit (a)(1)(A) to the Schedule TO-T filed by the Purchaser on May 12, 2026).
   
(a)(1)(B)
Letter of Transmittal (including Internal Revenue Service Form W-9) (incorporated by reference to Exhibit (a)(1)(B) to the Schedule TO-T filed by the Purchaser on May 12, 2026).
   
(a)(1)(C)
Press Release issued by the Purchaser on May 11, 2026 (incorporated by reference to Exhibit 99.1 to the Schedule TO-C filed by the Purchaser on May 11, 2026).
   
(a)(1)(D)
Summary Advertisement as published in The Wall Street Journal on May 12, 2026 (incorporated by reference to Exhibit (a)(1)(D) to the Schedule TO-T filed by the Purchaser on May 12, 2026).
   
(b)
None.
   
(d)(1)
Purchase Agreement, dated May 10, 2026, by and between the Purchaser and the Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on May 11, 2026).
   
(d)(2)
Form of Equity Distribution Agreement (incorporated by reference to Exhibit 10.23 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed on February 25, 2026).
   
(d)(3)
Amended and Restated Investment Advisory Agreement, dated as of June 16, 2021, by and between the Company and the Adviser (incorporated by reference to Exhibit 10.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed on February 25, 2026).
   
(d)(4)
Administration Agreement, dated as of April 9, 2018, by and between the Company and the Adviser (incorporated by reference to Exhibit 10.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 filed on February 25, 2026).
   
(d)(5)
Amendment No. 1 to Third Amended and Restated Senior Secured Revolving Credit Agreement, dated as of May 8, 2026, by and among the Company, JPMorgan Chase Bank, N.A. and each of the lenders party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 filed on May 11, 2026).
   
(d)(6)
Underwriting Agreement, dated June 1, 2026, by and among the Company, the Adviser and BofA Securities, Inc., BMO Capital Markets Corp., J.P. Morgan Securities LLC, KKR Capital Markets LLC, RBC Capital Markets, LLC and SMBC Nikko Securities America, Inc., as representatives of the underwriters named in Schedule A thereto (incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on June 2, 2026).
   
(g)
None.
   
(h)
None.




SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: June 2, 2026

KKR Alternative Assets L.P.
 
     
By: KKR Alternative Assets Limited, its general partner
 
     
By:
/s/ Noah Greenhill
 
 
Name: Noah Greenhill
 
 
Title: Authorized Signatory
 
     
KKR Alternative Assets Limited
 
     
By:
/s/ Noah Greenhill
 
 
Name: Noah Greenhill
 
 
Title: Authorized Signatory